Stimulation of T cell immunity by arginine enhances survival in peritonitis.
T cell-mediated immunity may play a role in host responses to infection. Arginine is a known thymic and T cell stimulator which enhances host allogenic, mitogenic, and anti-tumor responses. We, therefore, examined the effect of arginine on the survival of rats with severe and lethal peritonitis induced by cecal ligation and double-needle puncture (CLP). In Experiment 1, arginine HCl (100 mg) was given bid by gavage starting immediately after CLP. In Experiment 2, the same dose of arginine was given by gavage bid for 3 days pre-CLP and continued thereafter. In Experiment 3, arginine was administered iv post-CLP (100 mg tid). Arginine had no effect on overall survival in Experiment 1. In Experiments 2 and 3, arginine therapy significantly increased survival at all times. A separate experiment was carried out to determine the reason for the differential response to arginine administered via gavage or iv post-CLP (Experiments 1 and 3). Nonseptic rats showed a 400% increase in plasma arginine 30 min after gavage with 100 mg arginine (P less than 0.001). No rise in plasma arginine was noted when arginine was administered by gavage post-CLP. The impaired intestinal absorption or markedly increased utilization of arginine in this septic model may explain why no improved survival was seen in Experiment 1. The mechanism for the improved survival with arginine therapy seen in Experiments 2 and 3 may be related to its known thymic and T cell immunostimulatory effects.
Madden
H P
HP
Department of Surgery, Sinai Hospital of Baltimore, Maryland 21215.
Breslin
R J
RJ
Wasserkrug
H L
HL
Efron
G
G
Barbul
A
A
D000818:Animals; D001120:Arginine / Q000627:therapeutic use*; D007111:Immunity, Cellular / Q000187:drug effects*; D007167:Immunotherapy; D007275:Injections, Intravenous; D008297:Male; D010538:Peritonitis / Q000401:mortality / Q000628:therapy*; D051381:Rats; D011919:Rats, Inbred Strains; D013601:T-Lymphocytes; D013997:Time Factors
D001120:Arginine